Cargando…

Immunogenicity of a vaccinia virus-based severe acute respiratory syndrome coronavirus 2 vaccine candidate

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines provide essential tools for the control of the COVID-19 pandemic. A number of technologies have been employed to develop SARS-CoV-2 vaccines, including the inactivated SARS-CoV-2 particles, mRNA to express viral spike protein, rec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mei, Shan, Fan, Zhangling, Liu, Xiaoman, Zhao, Fei, Huang, Yu, Wei, Liang, Hu, Yamei, Xie, Yu, Wang, Liming, Ai, Bin, Liang, Chen, Xu, Fengwen, Guo, Fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353262/ https://www.ncbi.nlm.nih.gov/pubmed/35935962 http://dx.doi.org/10.3389/fimmu.2022.911164

Ejemplares similares

MxB inhibits long interspersed element type 1 retrotransposition
por: Huang, Yu, et al.
Publicado: (2022)

SERINC5 restricts influenza virus infectivity
por: Zhao, Fei, et al.
Publicado: (2022)

Rapid and sensitive one-tube detection of mpox virus using RPA-coupled CRISPR-Cas12 assay
por: Zhao, Fei, et al.
Publicado: (2023)

IFITM3 Inhibits SARS-CoV-2 Infection and Is Associated with COVID-19 Susceptibility
por: Xu, Fengwen, et al.
Publicado: (2022)

MARCH8 inhibits influenza A virus infection by targeting viral M2 protein for ubiquitination-dependent degradation in lysosomes
por: Liu, Xiaoman, et al.
Publicado: (2021)

Mucosal and cellular immune responses elicited by nasal and intramuscular inoculation with ASFV candidate immunogens
por: Xu, Lulu, et al.
Publicado: (2023)

Enhancing the Immunogenicity of Vaccinia Virus
por: Shchelkunov, Sergei N., et al.
Publicado: (2022)

Immunogenicity and Protection After Vaccination With a Modified Vaccinia Virus Ankara-Vectored Yellow Fever Vaccine in the Hamster Model
por: Julander, Justin G., et al.
Publicado: (2018)

Genes that Control Vaccinia Virus Immunogenicity
por: Shchelkunov, S. N., et al.
Publicado: (2020)

Modified vaccinia virus Ankara as a vaccine against feline coronavirus: immunogenicity and efficacy
por: Hebben, Matthias, et al.
Publicado: (2004)

Immunogenic Cell Death Induction by Ionizing Radiation
por: Zhu, Mengqin, et al.
Publicado: (2021)

Designs and Characterization of Subunit Ebola GP Vaccine Candidates: Implications for Immunogenicity
por: Agnolon, Valentina, et al.
Publicado: (2020)

The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections
por: Hsu, Ren-Jun, et al.
Publicado: (2022)

Molecular Characterization, Phylogenetic, Expression, and Protective Immunity Analysis of OmpF, a Promising Candidate Immunogen Against Yersinia ruckeri Infection in Channel Catfish
por: Wang, Erlong, et al.
Publicado: (2018)

Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial
por: Koch, Till, et al.
Publicado: (2020)

Safety and Immunogenicity of Inactivated and Recombinant Protein SARS-CoV-2 Vaccines in Patients With Thyroid Cancer
por: Han, Yuling, et al.
Publicado: (2022)

Editorial: Ionizing radiation reprograms tumor immune microenvironment by inducing immunogenic cell death
por: Yu, Fei, et al.
Publicado: (2023)

Porcine Respiratory Coronavirus as a Model for Acute Respiratory Coronavirus Disease
por: Keep, Sarah, et al.
Publicado: (2022)

Vaccinia Virus Activation and Antagonism of Cytosolic DNA Sensing
por: El-Jesr, Misbah, et al.
Publicado: (2020)

Targeting protein glycosylation to regulate inflammation in the respiratory tract: novel diagnostic and therapeutic candidates for chronic respiratory diseases
por: Xie, Xiaofeng, et al.
Publicado: (2023)

Global trends of Vaccinia oncolytic virus therapy over the past two decades: Bibliometric and visual analysis
por: Bo, Liu, et al.
Publicado: (2023)

B Cell-Based Vaccine Transduced With ESAT6-Expressing Vaccinia Virus and Presenting α-Galactosylceramide Is a Novel Vaccine Candidate Against ESAT6-Expressing Mycobacterial Diseases
por: Kwon, Bo-Eun, et al.
Publicado: (2019)

Deletion of Vaccinia Virus A40R Gene Improves the Immunogenicity of the HIV-1 Vaccine Candidate MVA-B
por: Pérez, Patricia, et al.
Publicado: (2020)

Effect of seasonal coronavirus immune imprinting on the immunogenicity of inactivated COVID-19 vaccination
por: Yin, Di, et al.
Publicado: (2023)

CRISPR-Cas13a Inhibits HIV-1 Infection
por: Yin, Lijuan, et al.
Publicado: (2020)

Immunogenicity and Safety of the M72/AS01(E) Candidate Vaccine Against Tuberculosis: A Meta-Analysis
por: Ji, Zhenhua, et al.
Publicado: (2019)

Effect of the ati Gene Deletion on the Pathogenicity and Immunogenicity of the Vaccinia Virus
por: Yakubitskiy, S. N., et al.
Publicado: (2023)

The Neisseria gonorrhoeae Methionine Sulfoxide Reductase (MsrA/B) Is a Surface Exposed, Immunogenic, Vaccine Candidate
por: Jen, Freda E.-C., et al.
Publicado: (2019)

Immunogenicity and efficacy of a novel multi-patch SARS-CoV-2/COVID-19 vaccine candidate
por: Perdiguero, Beatriz, et al.
Publicado: (2023)

Limited Effectiveness of Psoralen- and Ultraviolet-Inactivated Vaccinia Virus on SHIV Infection
por: Glenn, L. Lee
Publicado: (2013)

Enhanced Efficacy of Vaccination With Vaccinia Virus in Old vs. Young Mice
por: Shmeleva, Evgeniya V., et al.
Publicado: (2019)

Immunogenic cell death: The cornerstone of oncolytic viro-immunotherapy
por: Palanivelu, Lalitha, et al.
Publicado: (2023)

Kinetics of severe acute respiratory syndrome coronavirus 2 infection antibody responses
por: Lin, Yajie, et al.
Publicado: (2022)

Single Immunization of a Vaccine Vectored by a Novel Recombinant Vaccinia Virus Affords Effective Protection Against Respiratory Syncytial Virus Infection in Cotton Rats
por: Russell, Marsha S., et al.
Publicado: (2021)

Phase I Safety and Immunogenicity Evaluation of MVA-CMDR, a Multigenic, Recombinant Modified Vaccinia Ankara-HIV-1 Vaccine Candidate
por: Currier, Jeffrey R., et al.
Publicado: (2010)

Phase 1 Safety and Immunogenicity Evaluation of ADMVA, a Multigenic, Modified Vaccinia Ankara-HIV-1 B'/C Candidate Vaccine
por: Vasan, Sandhya, et al.
Publicado: (2010)

γδT Cells Are Required for CD8(+) T Cell Response to Vaccinia Viral Infection
por: Dai, Rui, et al.
Publicado: (2021)

Increased attenuation but decreased immunogenicity by deletion of multiple vaccinia virus immunomodulators
por: Sumner, Rebecca P., et al.
Publicado: (2016)

Preclinical evaluation of safety and immunogenicity of a primary series intranasal COVID-19 vaccine candidate (BBV154) and humoral immunogenicity evaluation of a heterologous prime-boost strategy with COVAXIN (BBV152)
por: Sunagar, Raju, et al.
Publicado: (2022)

Chaperna-Mediated Assembly of Ferritin-Based Middle East Respiratory Syndrome-Coronavirus Nanoparticles
por: Kim, Young-Seok, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_elltij56a39nhg4oo0p56dbdio